Full View

The 10-year survival analysis of radiofrequency ablation for solitary hepatocellular carcinoma 5 cm or smaller: primary versus recurrent HCC

XM Bai, M Cui, W Yang, H Wang, S Wang, ZY Zhang… - Radiology, 2021 - pubs.rsna.org
Background Although favorable outcomes have been reported with radiofrequency ablation
(RFA) for limited hepatocellular carcinoma (HCC), the efficacy of this treatment for recurrent …
被引用次数：66 相关文章

The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.

XM Bai, M Cui, W Yang, H Wang, S Wang, ZY Zhang… - Radiology, 2021 - europepmc.org
Background Although favorable outcomes have been reported with radiofrequency ablation
(RFA) for limited hepatocellular carcinoma (HCC), the efficacy of this treatment for recurrent …

[引用][C] The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC

XM Bai, M Cui, W Yang, H Wang, S Wang, ZY Zhang… - Radiology, 2021 - cir.nii.ac.jp
The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular
Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC | CiNii Research CiNii 国立情報学 …

The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC

XM Bai, M Cui, W Yang, H Wang, S Wang… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Although favorable outcomes have been reported with radiofrequency ablation
(RFA) for limited hepatocellular carcinoma (HCC), the efficacy of this treatment for recurrent …